Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-label Study Evaluating the Efficacy and Safety of Hepatic Resection for Hepatocellular Carcinoma With Venous Thrombosis After Initial Atezolizumab Plus Bevacizumab Treatment

NCT04649489 is registered in ClinicalTrials.gov with Jia Fan as lead sponsor.

NCT NCT04649489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04649489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-label Study Evaluating the Efficacy and Safety of Hepatic Resection for Hepatocellular Carcinoma With Venous Thrombosis After Initial Atezolizumab Plus Bevacizumab Treatment
Lead sponsor
Jia Fan
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 19, 2021
Completion date
March 31, 2028
Enrollment
501 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

venous thrombosis